Slc5a1

UniProt ID: P53790
Organism: Rattus norvegicus
Review Status: COMPLETE
Aliases:
Sglt1 SGLT1 Na+/glucose cotransporter 1 Sodium/glucose cotransporter 1
📝 Provide Detailed Feedback

Gene Description

Sodium/glucose cotransporter 1 (SGLT1) is a high-affinity Na+-coupled symporter that actively transports D-glucose and D-galactose across the plasma membrane with 2:1 Na+:glucose stoichiometry. SGLT1 is the primary transporter for dietary hexose absorption across the apical brush-border membrane of enterocytes in the small intestine. In kidney, it functions in the S3 segment of proximal tubules for glucose reabsorption, handling approximately 3% of filtered glucose. Additionally serves as a water channel enabling passive water transport. Located at the blood-brain barrier in endothelial cells.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0016324 apical plasma membrane
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation based on phylogenetic inference. SGLT1 apical localization is well-established across mammals. Direct experimental evidence in rat shows SGLT1 at apical membrane in MDCK cells (PMID:11831390), blood-brain barrier endothelial cells (PMID:14986005), and kidney proximal tubule S3 segments (PMID:16204409).
Reason: Core localization for SGLT1 function. Phylogenetic inference is well-supported by multiple direct experimental studies in rat demonstrating apical membrane localization in intestinal epithelium, renal proximal tubules, and brain endothelial cells. The N-terminal domain determines apical targeting (PMID:11831390).
Supporting Evidence:
PMID:11831390
The products of N-terminal deletion clones up to the 19th amino acid were localized at the apical plasma membrane
PMID:14986005
Immunostaining suggested that SGLT1 is located in the luminal membrane of the endothelial cells
file:rat/Slc5a1/Slc5a1-deep-research-falcon.md
model: Edison Scientific Literature
GO:0016324 apical plasma membrane
IEA
GO_REF:0000044
ACCEPT
Summary: IEA annotation based on UniProtKB/Swiss-Prot subcellular location mapping. Redundant with IBA and IDA annotations for same term.
Reason: While redundant with IBA annotation, this IEA represents valid automated inference from UniProt subcellular location annotation. Duplicates are acceptable in GO as they represent independent evidence paths. Core localization is correct.
GO:0016324 apical plasma membrane
IDA
PMID:14986005
Localization of the Na+-D-glucose cotransporter SGLT1 in the...
ACCEPT
Summary: Direct experimental evidence from immunohistochemistry in rat brain capillaries showing SGLT1 in luminal (apical) membrane of blood-brain barrier endothelial cells.
Reason: High-quality experimental evidence demonstrating apical localization in brain endothelial cells. The study showed immunoreactivity in intracerebral capillaries with staining in the luminal membrane.
Supporting Evidence:
PMID:14986005
Immunostaining suggested that SGLT1 is located in the luminal membrane of the endothelial cells and in intracellular vesicles
GO:0016324 apical plasma membrane
IDA
PMID:11831390
The apical localization of SGLT1 glucose transporter is dete...
ACCEPT
Summary: Direct experimental evidence from MDCK cell localization studies showing rat SGLT1 localizes to apical plasma membrane. N-terminal deletion analysis identified apical targeting signals.
Reason: High-quality experimental evidence. Study used rat SGLT1 expressed in MDCK cells and demonstrated apical localization, with identification of the N-terminal targeting domain.
Supporting Evidence:
PMID:11831390
SGLT1, an isoform of Na+-dependent glucose cotransporters, is localized at the apical plasma membrane in the epithelial cells of the small intestine and the kidney
GO:0016324 apical plasma membrane
ISO
GO_REF:0000121
ACCEPT
Summary: ISO annotation transferred from other mammalian species by RGD. Redundant with multiple direct experimental annotations (IDA) for rat SGLT1.
Reason: Valid ortholog transfer that is consistent with direct rat experimental evidence. Duplicates are acceptable as independent evidence paths.
GO:0005886 plasma membrane
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: IBA annotation for plasma membrane localization. This is a parent term of apical plasma membrane (GO:0016324) which is the more specific correct localization.
Reason: While technically correct, this is less specific than apical plasma membrane. The more specific term GO:0016324 better captures SGLT1's polarized localization. Acceptable to retain as it captures the broader membrane context.
GO:0005886 plasma membrane
ISO
GO_REF:0000121
KEEP AS NON CORE
Summary: ISO annotation transferred from mammalian orthologs. Less specific than apical plasma membrane annotations.
Reason: Valid but less specific than apical plasma membrane. The more specific term GO:0016324 is preferred for capturing SGLT1's polarized epithelial localization.
GO:0031526 brush border membrane
IDA
PMID:14986005
Localization of the Na+-D-glucose cotransporter SGLT1 in the...
ACCEPT
Summary: Brush border membrane localization is well supported for intestinal SGLT1, but PMID:14986005 itself focuses on brain capillary localization. Accept the term based on direct intestinal apical membrane evidence from other sources.
Reason: The brush border membrane term is appropriate for intestinal SGLT1, even though PMID:14986005 is likely a misassigned reference. Experimental data from intestinal apical membrane preparations support this localization.
Supporting Evidence:
PMID:17272350
Western blotting showed that in each case there was a significant decrease in apical GLUT2 level, but no change in SGLT1 level.
GO:0031526 brush border membrane
IDA
PMID:17272350
Apical GLUT2 and Cav1.3: regulation of rat intestinal glucos...
ACCEPT
Summary: Direct experimental evidence showing SGLT1 at intestinal brush border membrane in rat jejunum. Western blotting confirmed SGLT1 presence in apical membrane preparations.
Reason: High-quality experimental evidence demonstrating SGLT1 at brush border membrane of rat intestinal epithelium. This is a core localization for intestinal glucose absorption.
Supporting Evidence:
PMID:17272350
Western blotting showed that in each case there was a significant decrease in apical GLUT2 level, but no change in SGLT1 level
GO:0005903 brush border
ISO
GO_REF:0000121
MODIFY
Summary: ISO annotation for brush border localization. Brush border (GO:0005903) is the parent of brush border membrane (GO:0031526). The more specific membrane term is more accurate for a transmembrane transporter.
Reason: For a transmembrane transporter, the more specific term brush border membrane (GO:0031526) is more appropriate than the general brush border term.
Proposed replacements: brush border membrane
GO:0016020 membrane
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: Very general IEA annotation based on InterPro record mapping. SGLT1 has many more specific membrane annotations (apical plasma membrane, brush border membrane).
Reason: This is too general to be informative. SGLT1 has specific annotations to apical plasma membrane and brush border membrane that are much more informative. While technically correct, this adds no useful information.
GO:0043226 organelle
IDA
PMID:14986005
Localization of the Na+-D-glucose cotransporter SGLT1 in the...
MODIFY
Summary: The paper mentions intracellular vesicles containing SGLT1 in brain endothelial cells. However, 'organelle' is extremely vague and should be more specific.
Reason: The paper specifically mentions intracellular vesicles, not generic organelles. A more specific term would be appropriate if we want to capture this localization.
Proposed replacements: cytoplasmic vesicle
Supporting Evidence:
PMID:14986005
Immunostaining suggested that SGLT1 is located in the luminal membrane of the endothelial cells and in intracellular vesicles
GO:0016323 basolateral plasma membrane
TAS
PMID:14986005
Localization of the Na+-D-glucose cotransporter SGLT1 in the...
REMOVE
Summary: Questionable annotation. PMID:14986005 specifically shows SGLT1 in the LUMINAL (apical) membrane of brain endothelial cells, not basolateral. This appears to be an error in annotation.
Reason: The cited paper explicitly states SGLT1 is in the luminal membrane, which is the apical/blood-facing side of brain capillary endothelium, not basolateral. SGLT1 is canonically an apical transporter; basolateral glucose exit is mediated by GLUT2.
Supporting Evidence:
PMID:14986005
Immunostaining suggested that SGLT1 is located in the luminal membrane of the endothelial cells
GO:0005911 cell-cell junction
IDA
PMID:17090404
Asymmetric subcellular distribution of glucose transporters ...
KEEP AS NON CORE
Summary: Direct experimental evidence showing SGLT1 clusters at cell-cell junctions in arterial endothelium. High-density clusters found in proximity to cell-to-cell junctions.
Reason: Valid experimental finding in endothelial cells showing SGLT1 clustering near cell-cell junctions. This represents a secondary localization pattern in vascular endothelium, not the primary physiological localization in intestine/kidney.
Supporting Evidence:
PMID:17090404
Clusters of the glucose transporter isoforms were found at a high density in proximity to the cell-to-cell junctions
GO:0005769 early endosome
ISO
GO_REF:0000121
KEEP AS NON CORE
Summary: ISO annotation from mammalian orthologs. SGLT1 trafficking through endosomal compartments is plausible for membrane protein recycling.
Reason: Likely reflects trafficking/recycling rather than steady-state functional localization. Not a core localization but may be valid for protein turnover.
GO:0048471 perinuclear region of cytoplasm
ISO
GO_REF:0000121
KEEP AS NON CORE
Summary: ISO annotation from orthologs. May reflect biosynthetic pathway localization (ER/Golgi) rather than functional localization.
Reason: Likely reflects biosynthetic pathway (ER/Golgi in perinuclear region) rather than functional localization. Not a core localization for SGLT1 function.
GO:0005412 D-glucose:sodium symporter activity
IBA
GO_REF:0000033
ACCEPT
Summary: Core molecular function of SGLT1 - IBA based on phylogenetic inference. This is the defining activity of the SGLT1 transporter family.
Reason: This is THE core molecular function of SGLT1. The transporter catalyzes 2 Na+ : 1 D-glucose cotransport as established across all species. UniProt confirms this catalytic activity with Rhea reaction annotation.
Supporting Evidence:
PMID:15829715
the renal brush-border membrane Na+/glucose co-transporter-1 (SGLT1) is a molecular target for Cd2+ toxicity
GO:0005412 D-glucose:sodium symporter activity
ISO
GO_REF:0000121
ACCEPT
Summary: ISO annotation from mammalian orthologs. Consistent with direct rat evidence.
Reason: Core molecular function, well-supported by direct rat experimental evidence and consistent phylogenetic conservation.
GO:0005412 D-glucose:sodium symporter activity
IDA
PMID:15829715
The endogenous CXXC motif governs the cadmium sensitivity of...
ACCEPT
Summary: Direct experimental evidence showing rat SGLT1 Na+/glucose cotransport activity. Study used methyl-D-glucopyranoside uptake assays in SGLT1-expressing cells.
Reason: High-quality direct experimental evidence demonstrating the core molecular function in rat SGLT1.
Supporting Evidence:
PMID:15829715
Cd2+ acted as a noncompetitive, partial inhibitor of methyl-D-glucopyranoside uptake in vesicles from COS-7 cells transiently expressing SGLT1
GO:0005412 D-glucose:sodium symporter activity
TAS
PMID:11831390
The apical localization of SGLT1 glucose transporter is dete...
ACCEPT
Summary: TAS annotation from paper on SGLT1 apical localization. Paper discusses SGLT1 as glucose transporter but main focus is localization not transport activity.
Reason: The paper refers to SGLT1's known function as Na+-dependent glucose cotransporter. While the experimental focus is localization, the stated function is accurate.
Supporting Evidence:
PMID:11831390
SGLT1, an isoform of Na+-dependent glucose cotransporters, is localized at the apical plasma membrane
GO:0015371 galactose:sodium symporter activity
ISO
GO_REF:0000121
ACCEPT
Summary: ISO annotation for galactose transport. SGLT1 transports both D-glucose and D-galactose with similar affinity - this is well-established in the literature.
Reason: Core molecular function. SGLT1 transports D-galactose as well as D-glucose, both with high affinity. UniProt catalytic activity annotation confirms this. PMID:16204409 used galactose uptake to measure SGLT1 activity.
Supporting Evidence:
PMID:16204409
The phlorizin-sensitive uptake of d-[(3)H]galactose in BBM vesicles
GO:0015371 galactose:sodium symporter activity
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation based on sequence similarity. Consistent with ISO annotation and UniProt functional annotation.
Reason: Core molecular function. Galactose transport by SGLT1 is well-established and conserved across species.
GO:0005372 water transmembrane transporter activity
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation for water transport. SGLT1 functions as a water channel with high water conductivity comparable to aquaporins, enabling passive water transport.
Reason: Core molecular function. UniProt describes SGLT1 as having high water conductivity comparable to aquaporins, enabling passive water transport in response to osmotic gradients created during sugar/Na+ uptake.
GO:0005372 water transmembrane transporter activity
ISO
GO_REF:0000121
ACCEPT
Summary: ISO annotation from orthologs for water transport activity.
Reason: Core molecular function. Water transport by SGLT1 is well-documented and important for transepithelial water permeability in intestine.
GO:0055056 D-glucose transmembrane transporter activity
ISO
GO_REF:0000121
KEEP AS NON CORE
Summary: ISO annotation for general glucose transporter activity. This is less specific than D-glucose:sodium symporter activity which captures the coupling mechanism.
Reason: While correct, this is less informative than D-glucose:sodium symporter activity (GO:0005412) which specifies the sodium-coupling mechanism that defines SGLT1.
GO:0015151 alpha-glucoside transmembrane transporter activity
ISO
GO_REF:0000121
MARK AS OVER ANNOTATED
Summary: ISO annotation for alpha-glucoside transport. SGLT1 transports glucose (an alpha-glucoside in its cyclic form), but this term is typically used for disaccharide transport (e.g., maltose, sucrose). May be an over-annotation.
Reason: SGLT1 transports monosaccharides (glucose, galactose), not alpha-glucosides like maltose or sucrose. The more accurate term is D-glucose:sodium symporter activity. This term implies transport of glycosides/disaccharides which is not the primary function.
GO:0015293 symporter activity
IEA
GO_REF:0000043
MARK AS OVER ANNOTATED
Summary: IEA annotation from UniProtKB keyword mapping. Very general term.
Reason: Too general. The specific term D-glucose:sodium symporter activity (GO:0005412) is much more informative and captures the actual substrate specificity.
GO:0022857 transmembrane transporter activity
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: Very general IEA annotation from InterPro mapping.
Reason: Far too general to be informative. Specific molecular function annotations (D-glucose:sodium symporter activity) provide the relevant information.
GO:0008324 monoatomic cation transmembrane transporter activity
IEA
GO_REF:0000117
MARK AS OVER ANNOTATED
Summary: IEA from ARBA machine learning. SGLT1 uses Na+ gradient to drive glucose transport but is not primarily a cation transporter - it is a sugar transporter.
Reason: Misleading annotation. While SGLT1 translocates Na+ ions, it is primarily a sugar transporter that uses the Na+ gradient as driving force. The sodium transport is coupled to/incidental to the primary glucose transport function.
GO:0001951 intestinal D-glucose absorption
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation for intestinal glucose absorption - THE core biological process for SGLT1 in the gut.
Reason: Core biological process. SGLT1 is the primary transporter for dietary glucose absorption across enterocyte brush border membrane.
Supporting Evidence:
PMID:17272350
We have proposed a model of intestinal glucose absorption in which transport by SGLT1 induces rapid insertion and activation of GLUT2
GO:0001951 intestinal D-glucose absorption
ISO
GO_REF:0000121
ACCEPT
Summary: ISO annotation from orthologs. Consistent with direct rat evidence.
Reason: Core biological process, well-supported by rat experimental evidence.
GO:0001951 intestinal D-glucose absorption
TAS
PMID:15829715
The endogenous CXXC motif governs the cadmium sensitivity of...
ACCEPT
Summary: TAS annotation. The paper's main focus is cadmium inhibition of SGLT1, but mentions intestinal glucose absorption as established SGLT1 function.
Reason: Core biological process. While paper focuses on cadmium effects, it references SGLT1's role in intestinal glucose absorption.
Supporting Evidence:
PMID:15829715
2005 Apr 13. The endogenous CXXC motif governs the cadmium sensitivity of the renal Na+/glucose co-transporter.
GO:0035623 renal D-glucose absorption
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for renal glucose reabsorption. SGLT1 handles glucose reabsorption in S3 segment of proximal tubule (minor fraction, ~3% of total).
Reason: Core biological process. PMID:16204409 directly demonstrates SGLT1 in rat kidney S3 proximal tubule segments with functional glucose transport activity.
Supporting Evidence:
PMID:16204409
SGLT1 (SLC5A1) mediates a part of glucose and galactose reabsorption in the mammalian proximal tubule
PMID:16204409
the expression of SGLT1 is represented by a 75-kDa protein localized largely in the PT S3 segments
GO:0035623 renal D-glucose absorption
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation from sequence similarity. Consistent with direct rat evidence.
Reason: Core biological process, well-supported by direct rat experimental evidence.
GO:0035623 renal D-glucose absorption
ISO
GO_REF:0000121
ACCEPT
Summary: ISO annotation from orthologs. Consistent with IBA and direct rat evidence.
Reason: Core biological process with strong experimental support in rat.
GO:0098708 D-glucose import across plasma membrane
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for glucose import. Accurate description of SGLT1's transport direction (import into cell).
Reason: Core biological process. SGLT1 imports glucose from lumen into epithelial cells. This is a fundamental aspect of its transport function.
GO:0098708 D-glucose import across plasma membrane
ISO
GO_REF:0000121
ACCEPT
Summary: ISO annotation from orthologs. Consistent with IBA annotation.
Reason: Core biological process describing the import direction of SGLT1-mediated glucose transport.
GO:1904659 D-glucose transmembrane transport
ISO
GO_REF:0000121
ACCEPT
Summary: ISO annotation for glucose transmembrane transport.
Reason: Core biological process. This is the primary transport function of SGLT1.
GO:1904659 D-glucose transmembrane transport
TAS
PMID:11831390
The apical localization of SGLT1 glucose transporter is dete...
ACCEPT
Summary: TAS annotation. Paper focuses on localization but references SGLT1's glucose transport function.
Reason: Core biological process. While paper's experimental focus is localization, SGLT1's glucose transport function is accurately referenced.
Supporting Evidence:
PMID:11831390
SGLT1 glucose transporter...plays a pivotal role in the absorption and reabsorption of sugars
GO:0015757 galactose transmembrane transport
IEA
GO_REF:0000108
ACCEPT
Summary: IEA annotation based on logical inference. SGLT1 transports galactose with similar affinity to glucose - this is experimentally demonstrated in rat.
Reason: Core biological process. Galactose transport by SGLT1 is well-established. PMID:16204409 used galactose uptake assays to measure rat SGLT1 activity.
Supporting Evidence:
PMID:16204409
SGLT1 (SLC5A1) mediates a part of glucose and galactose reabsorption in the mammalian proximal tubule
GO:0050892 intestinal absorption
TAS
PMID:16204409
Rat renal glucose transporter SGLT1 exhibits zonal distribut...
ACCEPT
Summary: TAS annotation. The paper primarily focuses on kidney, though it mentions intestinal absorption as SGLT1 function.
Reason: Core biological process. SGLT1's role in intestinal absorption is well-established.
Supporting Evidence:
PMID:16204409
SGLT1 (SLC5A1) mediates a part of glucose and galactose reabsorption in the mammalian proximal tubule
GO:0050892 intestinal absorption
ISO
GO_REF:0000121
ACCEPT
Summary: ISO annotation from orthologs. Consistent with known SGLT1 function.
Reason: Core biological process for SGLT1 in the gut.
GO:0035377 transepithelial water transport
ISO
GO_REF:0000121
ACCEPT
Summary: ISO annotation for water transport function. SGLT1 acts as a water channel with high conductivity comparable to aquaporins.
Reason: Core biological process. SGLT1's water transport activity is important for intestinal water absorption coupled to glucose/Na+ uptake.
GO:0098719 sodium ion import across plasma membrane
ISO
GO_REF:0000121
KEEP AS NON CORE
Summary: ISO annotation for sodium import. SGLT1 couples 2 Na+ import per glucose.
Reason: While technically accurate (SGLT1 imports 2 Na+ per glucose), sodium transport is secondary to the primary function of glucose transport. The Na+ gradient drives glucose uptake rather than being the primary transported substrate.
GO:0006814 sodium ion transport
IEA
GO_REF:0000043
KEEP AS NON CORE
Summary: IEA annotation from UniProtKB keyword mapping.
Reason: While Na+ is cotransported with glucose, this annotation may give the misleading impression that SGLT1 is primarily a sodium transporter. The primary function is glucose transport using the Na+ gradient.
GO:0006811 monoatomic ion transport
IEA
GO_REF:0000043
MARK AS OVER ANNOTATED
Summary: Very general IEA annotation for ion transport.
Reason: Too general and misleading. SGLT1 is a sugar transporter that cotransports sodium, not primarily an ion transporter.
GO:0055085 transmembrane transport
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: Very general IEA annotation from InterPro mapping.
Reason: Far too general to be informative. Specific process annotations provide the relevant information about SGLT1 function.
GO:0150104 transport across blood-brain barrier
ISO
GO_REF:0000121
KEEP AS NON CORE
Summary: ISO annotation for BBB transport. Rat experimental evidence shows SGLT1 in brain capillary endothelium with upregulation after ischemia.
Reason: Valid annotation supported by rat experimental evidence (PMID:14986005). Not a core function (intestine/kidney are primary sites) but represents an established secondary physiological role.
Supporting Evidence:
PMID:14986005
The data suggest that SGLT1 participates in transport of D-glucose across the blood-brain barrier
GO:1902476 chloride transmembrane transport
ISO NOT
GO_REF:0000121
UNDECIDED
Summary: ISO annotation for chloride transport. This is unexpected - SGLT1 is not known as a chloride transporter. May be an erroneous annotation.
Reason: SGLT1 is a Na+/glucose symporter, not a chloride transporter. The basis for this annotation is unclear. Would need to trace the original evidence from the ortholog to evaluate. Marking as undecided pending clarification.
GO:0000017 alpha-glucoside transport
ISO
GO_REF:0000121
MARK AS OVER ANNOTATED
Summary: ISO annotation for alpha-glucoside transport. SGLT1 transports monosaccharides, not glucosides (which typically refers to disaccharides).
Reason: SGLT1 transports D-glucose and D-galactose (monosaccharides), not alpha-glucosides like maltose or sucrose. This term is misleading for SGLT1's actual substrate specificity.
GO:0009758 carbohydrate utilization
IDA
PMID:25592016
Induction of histone H3K4 methylation at the promoter, enhan...
MODIFY
Summary: IDA annotation from study on dietary regulation of Sglt1 gene expression. The paper shows epigenetic regulation (H3K4 methylation) of Sglt1 in response to high-starch diet, not direct SGLT1 involvement in carbohydrate utilization.
Reason: The paper demonstrates transcriptional regulation of Sglt1 by diet, not a direct role for SGLT1 protein in carbohydrate utilization. The appropriate process would be related to glucose absorption/transport, not utilization.
Proposed replacements: intestinal D-glucose absorption
Supporting Evidence:
PMID:25592016
Feeding rats the high-starch/low-fat diet induced mono-, di-, and trimethylation of histone H3K4 on the promoter and transcribed regions of the Si and Sglt1 genes
GO:0001656 metanephros development
ISO
GO_REF:0000121
UNDECIDED
Summary: ISO annotation for kidney development. SGLT1 is a glucose transporter that is expressed during kidney development but is not known to have a developmental signaling role.
Reason: The basis for this developmental annotation is unclear. SGLT1 may be expressed during kidney development but is primarily a glucose transporter, not a developmental regulator. Would need to evaluate the original ortholog evidence.

Core Functions

Primary molecular function - electrogenic Na+-coupled D-glucose symporter with 2:1 Na+:glucose stoichiometry

Co-transports D-galactose with sodium using same mechanism as glucose transport

Acts as water channel with high conductivity comparable to aquaporins

References

Gene Ontology annotation through association of InterPro records with GO terms
Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
Automatic assignment of GO terms using logical inference, based on inter-ontology links
Electronic Gene Ontology annotations created by ARBA machine learning models
RGD ISO annotations to rat from other mammalian species
The apical localization of SGLT1 glucose transporter is determined by the short amino acid sequence in its N-terminal domain.
  • N-terminal domain (first 19 amino acids) determines apical localization in MDCK cells
    "The products of N-terminal deletion clones up to the 19th amino acid were localized at the apical plasma membrane, whereas the products of N-terminal 20- and 23-amino-acid deletion clones were localized along the entire plasma membrane."
  • D28 mutations cause cytoplasmic retention
    "The products of D28N and D28G clones were localized in the cytoplasm, showing that the aspartic acid-28 may be essential for the delivery of SGLT1 to the plasma membrane."
Localization of the Na+-D-glucose cotransporter SGLT1 in the blood-brain barrier.
  • SGLT1 located in luminal membrane of brain capillary endothelial cells
    "Immunostaining suggested that SGLT1 is located in the luminal membrane of the endothelial cells and in intracellular vesicles."
  • Also found in intracellular vesicles
    "Immunostaining suggested that SGLT1 is located in the luminal membrane of the endothelial cells and in intracellular vesicles."
  • SGLT1 mRNA upregulated after brain ischemia
    "1 day after a transient occlusion of the right middle cerebral artery, SGLT1 mRNA was detected in capillaries of both brain hemispheres."
The endogenous CXXC motif governs the cadmium sensitivity of the renal Na+/glucose co-transporter.
  • SGLT1 is a target for Cd2+ toxicity via CXXC motif
    "the renal brush-border membrane Na+/glucose co-transporter-1 (SGLT1) is a molecular target for Cd2+ toxicity"
  • Demonstrated Na+/glucose cotransport activity
    "Cd2+ acted as a noncompetitive, partial inhibitor of methyl-D-glucopyranoside uptake in vesicles from COS-7 cells transiently expressing SGLT1"
Rat renal glucose transporter SGLT1 exhibits zonal distribution and androgen-dependent gender differences.
  • SGLT1 localized to S3 segment of proximal tubule
    "the expression of SGLT1 is represented by a 75-kDa protein localized largely in the PT S3 segments"
  • Gender differences in expression (female > male)
    "In tissue cryosections, the antibody strongly stained BBM of the S3 PT segments in the OS and medullary rays (F > M)"
  • Androgen-dependent regulation
    "castration upregulated, whereas treatment of castrated rats with testosterone, but not with estradiol or progesterone, downregulated the 75-kDa protein"
Asymmetric subcellular distribution of glucose transporters in the endothelium of small contractile arteries.
  • SGLT1 present in vascular endothelium
    "We identified GLUT-1 to -5 and SGLT-1 in the endothelial cells of all three vascular beds."
  • Clusters at cell-cell junctions
    "Clusters of the glucose transporter isoforms were found at a high density in proximity to the cell-to-cell junctions."
Apical GLUT2 and Cav1.3: regulation of rat intestinal glucose and calcium absorption.
  • SGLT1 at brush border membrane of jejunum
    "Western blotting showed that in each case there was a significant decrease in apical GLUT2 level, but no change in SGLT1 level."
  • SGLT1 transport initiates GLUT2 insertion
    "We have proposed a model of intestinal glucose absorption in which transport by SGLT1 induces rapid insertion and activation of GLUT2 in the apical membrane"
  • SGLT1 component is phloretin-insensitive
    "the phloretin-insensitive SGLT1 component of glucose absorption"
Induction of histone H3K4 methylation at the promoter, enhancer, and transcribed regions of the Si and Sglt1 genes in rat jejunum in response to a high-starch/low-fat diet.
  • Sglt1 gene expression induced by high-starch diet
    "induction of Si and Sglt1 gene expression in rat jejunum by a high-starch/low-fat diet intake is positively associated with histone H3K4 methylation"
  • Epigenetic regulation via H3K4 methylation
    "Feeding rats the high-starch/low-fat diet induced mono-, di-, and trimethylation of histone H3K4 on the promoter and transcribed regions of the Si and Sglt1 genes"
file:rat/Slc5a1/Slc5a1-deep-research-falcon.md
Deep research report on Slc5a1

Deep Research

Falcon

(Slc5a1-deep-research-falcon.md)
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 16 citations 2026-01-14T20:39:14.973351

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan status and verification
We verified the target identity: Slc5a1 encodes sodium/glucose cotransporter 1 (SGLT1) in Rattus norvegicus. The collected evidence consistently describes a sodium:solute symporter (SSF family) that mediates 2 Na+ per glucose cotransport, is apically localized in intestinal enterocytes and in the S3 (late) segment of the proximal tubule, and is detected in heart—aligning with the UniProt P53790 annotation and SSF family/domain context (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88).

Executive summary
SGLT1 (Slc5a1) is a high‑affinity Na+-coupled symporter for D‑glucose and D‑galactose with 2:1 Na+:glucose stoichiometry. In rat, it operates at the apical (brush‑border) membrane of small‑intestinal enterocytes to absorb dietary hexoses and in the S3 segment of the renal proximal tubule to reclaim a minor fraction of filtered glucose; it is also present in cardiomyocytes and other cardiac cells. Mechanistically, it follows an alternating‑access transport cycle characteristic of SSF transporters. SGLT1 is dynamically regulated by luminal carbohydrate and apical β2‑adrenergic receptor signaling (via PKA) that rapidly increases apical SGLT1 availability in rat intestine. Perturbations of SGLT1 function contribute to diarrheal pathophysiology and may shape renal compensation when SGLT2 is inhibited. Translationally, dual SGLT1/2 inhibitors (e.g., sotagliflozin) and intestine‑restricted SGLT1 inhibitors (e.g., LX2761) leverage these mechanisms but can cause GI adverse events when intestinal SGLT1 is inhibited. Key quantitative features and up‑to‑date references are summarized below (paulussen2023theβ2adrenergicreceptor pages 11-14, azizogli2023comparisonofsglt1 pages 3-5, rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70, kharve2024impactofdrugmediated pages 4-7).

Key concepts and definitions
• Primary function and substrates: SGLT1 is a Na+-dependent symporter for D‑glucose and D‑galactose, not fructose; it is characterized as high‑affinity/low‑capacity relative to SGLT2 (human/rodent consensus). The canonical stoichiometry is 2 Na+ per glucose, supporting uphill sugar transport (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Frontiers in Molecular Biosciences, 2025, https://doi.org/10.3389/fmolb.2025.1668400) (azizogli2023comparisonofsglt1 pages 3-5, kaijage2025molecularmechanismsand pages 2-3).
• Transport mechanism: SGLT1 conforms to the sodium:solute symporter (SSF) family’s Na+-coupled alternating‑access mechanism; structural advances in family members (SGLT2) and comparative analyses illuminate conserved motifs and gating transitions relevant to SGLT1 (Frontiers in Molecular Biosciences, 2025, https://doi.org/10.3389/fmolb.2025.1668400) (kaijage2025molecularmechanismsand pages 2-3).
• Localization in rat tissues: SGLT1 is apical in small‑intestinal enterocytes (brush border), localized to the late proximal tubule (S3) in kidney (contributing a minor fraction of renal glucose reabsorption), and expressed in cardiomyocytes and other cardiac cell types (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; preclinical/translational review, 2024) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88, mroueh2024preclinicalandtranslationala pages 84-88).

Recent developments and latest research (2023–2024 emphasis)
• Apical β2‑AR control of rat intestinal SGLT1: In everted rat intestinal sacs, epinephrine (10 μM) increased luminal‑to‑tissue glucose accumulation from 440 ± 132 to 833 ± 255 μM; this was prevented by the β2‑AR antagonist ICI 118,551 and was >90% suppressed by SGLT inhibitors (phlorizin 100 μM; LX4211 2 μM). Colchicine blocked the epinephrine effect without altering basal uptake, indicating β2‑AR–PKA‑dependent translocation of SGLT1 to the brush border (Frontiers in Cell and Developmental Biology, 2023, https://doi.org/10.3389/fcell.2022.1041930) (paulussen2023theβ2adrenergicreceptor pages 11-14).
• Segmental intestinal regulation and incretin coupling: Recent syntheses highlight SGLT1’s proximal>distal intestinal gradient and its role in glucose‑dependent GLP‑1/GIP secretion, with pharmacologic or genetic inhibition blunting incretin responses; SGLT1 expression is responsive to luminal carbohydrate (Rottenberger, 2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70).
• Kidney physiology context and distribution of work between SGLTs: Contemporary analyses reiterate that early proximal SGLT2 handles the large majority of filtered glucose and SGLT1 in late S2/S3 reclaims the remainder; estimates include ~97% via SGLT2 vs ~3% via SGLT1 (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143) (azizogli2023comparisonofsglt1 pages 3-5).
• Intestinal transporter safety and drug interactions: A 2024 scoping analysis emphasizes that intestinal SGLT1 inhibition (e.g., dual SGLT1/2 inhibitors) can cause carbohydrate malabsorption and diarrhea; it catalogues intestinal transporter roles and potential unintended nutrient disposition changes (Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (kharve2024impactofdrugmediated pages 4-7).

Current applications and real‑world implementations
• Dual SGLT1/2 inhibition: Sotagliflozin (LX4211) improves glycemic control by combining renal glucose excretion (SGLT2) with reduced postprandial intestinal absorption (SGLT1), but GI adverse effects reflect on‑target intestinal SGLT1 inhibition (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (azizogli2023comparisonofsglt1 pages 3-5, kharve2024impactofdrugmediated pages 4-7).
• Intestine‑restricted SGLT1 inhibition: LX2761 (nonabsorbable) is designed to limit systemic exposure and confine SGLT1 inhibition to the gut, aiming to reduce postprandial glycemia while mitigating systemic effects; reviews summarize its rationale and emergence (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (azizogli2023comparisonofsglt1 pages 3-5, kharve2024impactofdrugmediated pages 4-7).
• Selectivity ranking among marketed SGLT2 inhibitors: PBPK analysis indicates dual inhibitor sotagliflozin has the highest SGLT1 inhibition among tested agents, followed by ertugliflozin and empagliflozin (Frontiers in Pharmacology, 2023, https://doi.org/10.3389/fphar.2023.1142003) (kharve2024impactofdrugmediated pages 4-7).

Expert opinions and analysis
• Integrative positioning of SGLT1 in cardiorenal‑metabolic axis: Reviews synthesize that SGLT1 is high‑affinity/low‑capacity, localized to intestinal brush border and renal S3, and present in heart; SGLT1’s role becomes more prominent when SGLT2 is inhibited, with potential downstream compensations in late proximal segments (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; preclinical/translational review, 2024) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88).
• Intestinal endocrine–absorptive crosstalk: Contemporary analyses underscore SGLT1’s involvement in enteroendocrine sensing and incretin secretion, framing therapy designs (e.g., intestine‑restricted SGLT1 inhibitors) to modulate postprandial excursions while considering GI tolerability (Rottenberger, 2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70).

Relevant statistics and quantitative data
• Stoichiometry: SGLT1 couples 2 Na+ to 1 glucose (vs SGLT2’s 1:1), enabling higher uphill transport capability per cycle (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143) (azizogli2023comparisonofsglt1 pages 3-5).
• Renal fractional reabsorption: Approximate division of filtered glucose reabsorption: ~97% SGLT2 (S1/S2) vs ~3% SGLT1 (late S2/S3) (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143) (azizogli2023comparisonofsglt1 pages 3-5).
• Rat intestinal β2‑AR regulation experiment: Epinephrine (10 μM) approximately doubled SGLT‑mediated glucose accumulation in rat everted sacs (440 ± 132 → 833 ± 255 μM), blocked by β2‑AR antagonism and SGLT inhibitors; colchicine abolished the epinephrine effect, consistent with SGLT1 translocation (Frontiers in Cell and Developmental Biology, 2023, https://doi.org/10.3389/fcell.2022.1041930) (paulussen2023theβ2adrenergicreceptor pages 11-14).
• Clinical pharmacology context: Dual SGLT1/2 inhibition can provoke diarrhea due to unabsorbed intestinal carbohydrate and osmotic water retention when SGLT1 is inhibited (Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (kharve2024impactofdrugmediated pages 4-7).

Detailed synthesis by topic
1) Primary function, substrates, stoichiometry, mechanism
SGLT1 (Slc5a1) is the apical Na+-dependent glucose/galactose symporter responsible for active uptake against the luminal gradient, with 2 Na+ per glucose coupling and an alternating‑access mechanism typical of the SSF transporter family. This high‑affinity profile contrasts with SGLT2’s lower affinity and 1:1 coupling (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Frontiers in Molecular Biosciences, 2025, https://doi.org/10.3389/fmolb.2025.1668400) (azizogli2023comparisonofsglt1 pages 3-5, kaijage2025molecularmechanismsand pages 2-3).

2) Tissue and cellular localization in rat
• Intestine: SGLT1 is localized to the brush‑border (apical) membrane of enterocytes, mediating dietary glucose/galactose absorption. Rat experiments directly demonstrate SGLT‑dependent uptake in intestinal sacs and β2‑AR‑driven acute regulation (Frontiers in Cell and Developmental Biology, 2023, https://doi.org/10.3389/fcell.2022.1041930) (paulussen2023theβ2adrenergicreceptor pages 11-14).
• Kidney: In rat and other mammals, SGLT1 is localized to the late proximal tubule (S3), reclaiming the final portion of filtered glucose after the bulk reabsorption by SGLT2 in S1/S2 (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143) (azizogli2023comparisonofsglt1 pages 3-5).
• Heart: SGLT1 is detected in cardiomyocytes and other cardiac cell types; preclinical/translational compilations report upregulation in pressure/volume overload and diabetic/ischemic cardiomyopathy (preclinical/translational review, 2024) (mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88, mroueh2024preclinicalandtranslationala pages 84-88).

3) Mechanism and domains (SSF family)
SGLT1 is an SSF family member whose Na+-coupled alternating‑access cycle enables secondary active transport. Comparative structural biology across SGLTs (including SGLT2 cryo‑EM with MAP17) provides mechanistic insights into Na+-binding, gating transitions, and inhibitor binding modes that, by homology, inform SGLT1 annotation (Frontiers in Molecular Biosciences, 2025, https://doi.org/10.3389/fmolb.2025.1668400) (kaijage2025molecularmechanismsand pages 2-3).

4) Regulation by diet/fasting, hormones/GPCRs, kinases, ischemia
• Luminal carbohydrate and diurnal control: Intestinal SGLT1 expression/activity is upregulated by luminal carbohydrate and exhibits segment‑dependent regulation; contemporary syntheses highlight proximal > distal expression and incretin coupling as adaptive responses (Rottenberger, 2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70).
• β2‑AR/PKA signaling in rat intestine: β2‑adrenergic receptor at the apical membrane senses sugars and epinephrine, promoting PKA‑dependent SGLT1 translocation and enhanced uptake in rat enterocytes (Frontiers in Cell and Developmental Biology, 2023, https://doi.org/10.3389/fcell.2022.1041930) (paulussen2023theβ2adrenergicreceptor pages 11-14).
• PKC/PKA post‑translational modulation and cardiometabolic stresses: Reviews summarize PKA/PKC phosphorylation sites, leptin/insulin effects, and upregulation with pressure/volume overload or ischemic/diabetic cardiomyopathy; these compile mechanistic regulation relevant to SGLT1 in intestine and heart (preclinical/translational review, 2024) (mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88, mroueh2024preclinicalandtranslationala pages 84-88).

5) Roles in pathophysiology and compensatory changes
• Diarrhea: When intestinal SGLT1 is inhibited (e.g., dual SGLT1/2 inhibitors), carbohydrate malabsorption increases luminal osmotic load and water retention, leading to diarrhea; this mechanism is highlighted in transporter‑focused safety analyses (Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (kharve2024impactofdrugmediated pages 4-7).
• Renal compensation during SGLT2 inhibition: With SGLT2 blocked, glucose delivery distally increases and SGLT1 in late PT/S3 becomes proportionally more consequential, with downstream segmental adjustments (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; preclinical/translational review, 2024) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88).

6) Applications: SGLT1‑selective and dual inhibitors; selectivity and clinical findings
• Sotagliflozin (dual SGLT1/2) lowers postprandial and fasting glucose via intestinal and renal actions but has GI adverse effects consistent with intestinal SGLT1 inhibition. Contemporary comparisons and PBPK modeling rank sotagliflozin highest for SGLT1 inhibition among evaluated agents (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Frontiers in Pharmacology, 2023, https://doi.org/10.3389/fphar.2023.1142003) (azizogli2023comparisonofsglt1 pages 3-5, kharve2024impactofdrugmediated pages 4-7).
• LX2761 (nonabsorbable SGLT1 inhibitor) is designed to be gut‑restricted to reduce postprandial glycemia with reduced systemic exposure (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (azizogli2023comparisonofsglt1 pages 3-5, kharve2024impactofdrugmediated pages 4-7).

7) Quantitative parameters and data needs
• Stoichiometry and fractional renal contribution are well‑supported (2:1 Na+:glucose; ~3% SGLT1 renal reabsorption). Precise rat SGLT1 Km values were not directly resolved in the 2023–2024 sources identified here; the functional “high‑affinity” characterization is consistent across reviews and experimental contexts (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143) (azizogli2023comparisonofsglt1 pages 3-5).

Embedded summary table
| Aspect | Evidence / Quantitative value | Species / Preparation | Source (journal, year); URL/DOI |
|---|---|---:|---|
| Transport stoichiometry | 2 Na+ : 1 glucose; Na+-coupled alternating-access symport mechanism (mechanistic note: supports uphill glucose transport) (stoichiometry reported repeatedly) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88) | Mammalian / rat-characterized SGLT1 functional studies | Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Substrates & affinity | Transports D-glucose and D-galactose (high-affinity); does not transport fructose; described as high-affinity, low-capacity transporter (kaijage2025molecularmechanismsand pages 2-3, azizogli2023comparisonofsglt1 pages 3-5) | Human/rodent biochemical and transport assays | Frontiers in Molecular Biosciences, 2025; DOI: 10.3389/fmolb.2025.1668400 (kaijage2025molecularmechanismsand pages 2-3); Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Intestinal localization & β2-AR regulation | Apical brush-border of enterocytes; β2-adrenergic receptor (apical) stimulates SGLT1 translocation via PKA; rat everted-sac data: epinephrine (10 μM) increased luminal→tissue glucose accumulation 440 ±132 → 833 ±255 μM; effect blocked by β2 antagonist ICI 118,551 (10 μM); phlorizin (100 μM) or LX4211 (2 μM) inhibited >90% (paulussen2023theβ2adrenergicreceptor pages 11-14) | Rat, everted intestinal sac experiments (quantitative inhibitor/dose data) | Frontiers in Cell and Developmental Biology, Jan 2023; DOI: https://doi.org/10.3389/fcell.2022.1041930 (paulussen2023theβ2adrenergicreceptor pages 11-14) |
| Renal localization (nephron) | Localized to late proximal tubule (S3/late PT); contributes small fraction of renal reabsorption vs SGLT2 (reports: ~3%–<10% attributable to SGLT1 in kidney) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88) | Rodent/kidney segment expression & physiology analyses | Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Cardiac expression | Detected in cardiomyocytes, cardiac endothelial cells and other cardiac cell types; upregulated in pressure/volume overload and diabetic/ischemic cardiomyopathy (mroueh2024preclinicalandtranslationalb pages 84-88, rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) | Preclinical rodent and translational studies | Mroueh (2024) (pre-clinical/translational review) (mroueh2024preclinicalandtranslationalb pages 84-88); Rottenberger (2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) |
| Pathophysiology — CDI / diarrhea | Drug or toxin-mediated loss of intestinal SGLT1 activity can produce carbohydrate accumulation and osmotic diarrhea; SGLT1 inhibition (e.g., sotagliflozin) linked to diarrhoeal adverse events in humans/rodents (kharve2024impactofdrugmediated pages 4-7) | Clinical observations and translational reviews; rodent models referenced | Pharmaceutics, 2024; DOI: https://doi.org/10.3390/pharmaceutics16040447 (kharve2024impactofdrugmediated pages 4-7) |
| Compensation with SGLT2 inhibition | Downstream nephron segments (including S3) show compensatory changes after SGLT2 inhibition; SGLT1-mediated uptake/behaviour in late PT becomes more relevant when SGLT2 inhibited (compensatory reabsorption shift) (mroueh2024preclinicalandtranslationalb pages 84-88, azizogli2023comparisonofsglt1 pages 3-5) | Rodent pharmacology/pathophysiology reviews and PBPK modeling context | Mroueh (2024) (mroueh2024preclinicalandtranslationalb pages 84-88); Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Incretin coupling & intestinal gradient | SGLT1 in enterocytes and enteroendocrine cells couples luminal glucose to GLP-1/GIP secretion; expression shows proximal→distal gradient (higher proximal/duodenum) and is luminal-carbohydrate responsive (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70, azizogli2023comparisonofsglt1 pages 3-5) | Mouse/rodent and translational intestine studies; pharmacologic knockouts/inhibitors | Rottenberger (2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70); Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Water / urea permeation | SGLT1 can permit permeation of water and urea (functional uniport/permeation properties reported for SSF family members) (mroueh2024preclinicalandtranslationalb pages 84-88, rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) | Biophysical/functional transporter studies (mammalian/rodent) | Mroueh (2024) (mroueh2024preclinicalandtranslationalb pages 84-88); Rottenberger (2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) |
| Structural / mechanistic features | Alternating-access Na+-coupled mechanism conserved across SSF family; family motifs noted (e.g., Pro–Pro motif in related SGLTs) and structural advances inform inhibitor binding and state transitions (kaijage2025molecularmechanismsand pages 2-3, azizogli2023comparisonofsglt1 pages 3-5) | Structural biology, modeling and comparative analyses (human/orthologs) | Frontiers in Molecular Biosciences, 2025; DOI: 10.3389/fmolb.2025.1668400 (kaijage2025molecularmechanismsand pages 2-3); Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Inhibitors & selectivity (clinical/translational) | Sotagliflozin — dual SGLT1/SGLT2 (potent SGLT1 inhibition; reported in vitro IC50 ≈ 0.036 μM for SGLT2 with notable SGLT1 activity and GI effects); LX2761 — nonabsorbable SGLT1-targeted agent; PBPK ranking: sotagliflozin > ertugliflozin/empagliflozin for SGLT1 inhibition in some models (kharve2024impactofdrugmediated pages 4-7, azizogli2023comparisonofsglt1 pages 3-5) | Clinical trials, PBPK and translational studies; mixed human/rodent data | Pharmaceutics, 2024; DOI: https://doi.org/10.3390/pharmaceutics16040447 (kharve2024impactofdrugmediated pages 4-7); Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Quantitative renal handling | Clinical/physiological estimates: ≈97% of filtered glucose reabsorbed via SGLT2 (early PT); ≈3% by SGLT1 (late PT/S3) in several analyses (azizogli2023comparisonofsglt1 pages 3-5) | Integrated renal physiology estimates (rodent→human translational summaries) | Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Fasting / feeding regulation (jejunal) | Jejunal/segmental SGLT1 regulation: fasting increases jejunal SGLT1 activity/expression vs fed state (segment- and diet-dependent regulation conserved in rodents); a conserved paradigm for luminal carbohydrate-regulated expression (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) | Mouse/rodent Ussing-chamber and membrane fraction studies; inferred conservation to rat | Rottenberger (2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) |

Table: Compact, sourced summary table of functional, localization, regulatory and translational data for rat Slc5a1 (SGLT1, UniProt P53790), with primary citations to the gathered evidence for quick reference.

Mandatory verification (symbol, organism, family)
• Gene symbol Slc5a1 unambiguously matches the SGLT1 transporter in rat; the literature reviewed consistently refers to SGLT1’s intestinal/renal/cardiac expression and 2:1 Na+:glucose mechanism, matching UniProt P53790 and SSF family/domain annotations (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; preclinical/translational review, 2024) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88, mroueh2024preclinicalandtranslationala pages 84-88).

Limitations and open points
• Rat‑specific kinetic constants (Km) and fine‑grained nephron‑segment expression atlases were not located within the retrieved 2023–2024 sources; future inclusion of rat‑focused primary physiologic measurements would strengthen quantitative annotation. Nonetheless, the key qualitative and semi‑quantitative features (stoichiometry, localization, regulatory paradigms) are robustly supported here (azizogli2023comparisonofsglt1 pages 3-5, paulussen2023theβ2adrenergicreceptor pages 11-14).

References (URLs and dates)
• Paulussen F et al., 2023. Frontiers in Cell and Developmental Biology. The β2‑adrenergic receptor in the apical membrane of intestinal enterocytes senses sugars to stimulate glucose uptake from the gut. URL: https://doi.org/10.3389/fcell.2022.1041930 (published Jan 2023). (paulussen2023theβ2adrenergicreceptor pages 11-14)
• Azizogli A‑R et al., 2023. Advanced Therapeutics. Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus. URL: https://doi.org/10.1002/adtp.202300143 (Sep 2023). (azizogli2023comparisonofsglt1 pages 3-5)
• Rottenberger OF, 2024. Mechanisms underlying monosaccharide stimulated incretin hormone secretion from the intestine. Thesis/review with current synthesis (2024). (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70)
• Kharve K et al., 2024. Pharmaceutics. Impact of Drug‑Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought? URL: https://doi.org/10.3390/pharmaceutics16040447 (Mar 2024). (kharve2024impactofdrugmediated pages 4-7)
• Mroueh A, 2024. Pre‑clinical and translational studies of SGLT1/2 in arteries and hearts (review, 2024). (mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88, mroueh2024preclinicalandtranslationala pages 84-88)
• Kaijage N, Kraszewski S, 2025. Frontiers in Molecular Biosciences. Molecular mechanisms and computational insights into human SGLTs: advancing toward selective SGLT1 inhibition. URL: https://doi.org/10.3389/fmolb.2025.1668400 (Oct 2025) — used for mechanistic family context. (kaijage2025molecularmechanismsand pages 2-3)

References

  1. (azizogli2023comparisonofsglt1 pages 3-5): Abdul‐Rahman Azizogli, Michael R Vitti, Richa Mishra, Laura Osorno, Corey Heffernan, and Vivek A Kumar. Comparison of sglt1, sglt2, and dual inhibitor biological activity in treating type 2 diabetes mellitus. Advanced Therapeutics, Sep 2023. URL: https://doi.org/10.1002/adtp.202300143, doi:10.1002/adtp.202300143. This article has 17 citations and is from a peer-reviewed journal.

  2. (mroueh2024preclinicalandtranslationalb pages 84-88): A Mroueh. Pre-clinical and translational studies of the expression and role of sodium glucose co-transporters sglt1 and sglt2 in arteries and hearts under physiological and …. Unknown journal, 2024.

  3. (mroueh2024preclinicalandtranslational pages 84-88): A Mroueh. Pre-clinical and translational studies of the expression and role of sodium glucose co-transporters sglt1 and sglt2 in arteries and hearts under physiological and …. Unknown journal, 2024.

  4. (paulussen2023theβ2adrenergicreceptor pages 11-14): Frederik Paulussen, Chetan P. Kulkarni, Frank Stolz, Eveline Lescrinier, Stijn De Graeve, Suzan Lambin, Arnaud Marchand, Patrick Chaltin, Peter In't Veld, Joseph Mebis, Jan Tavernier, Patrick Van Dijck, Walter Luyten, and Johan M. Thevelein. The β2-adrenergic receptor in the apical membrane of intestinal enterocytes senses sugars to stimulate glucose uptake from the gut. Frontiers in Cell and Developmental Biology, Jan 2023. URL: https://doi.org/10.3389/fcell.2022.1041930, doi:10.3389/fcell.2022.1041930. This article has 2 citations and is from a poor quality or predatory journal.

  5. (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70): OF Rottenberger. Mechanisms underlying monosaccharide stimulated incretin hormone secretion from the intestine. Unknown journal, 2024.

  6. (kharve2024impactofdrugmediated pages 4-7): Kshitee Kharve, Andrew S. Engley, Mary F. Paine, and Jason A. Sprowl. Impact of drug-mediated inhibition of intestinal transporters on nutrient and endogenous substrate disposition…an afterthought? Pharmaceutics, 16:447, Mar 2024. URL: https://doi.org/10.3390/pharmaceutics16040447, doi:10.3390/pharmaceutics16040447. This article has 1 citations and is from a poor quality or predatory journal.

  7. (kaijage2025molecularmechanismsand pages 2-3): Nadhiri Kaijage and Sebastian Kraszewski. Molecular mechanisms and computational insights into human sglts: advancing toward selective sglt1 inhibition. Frontiers in Molecular Biosciences, Oct 2025. URL: https://doi.org/10.3389/fmolb.2025.1668400, doi:10.3389/fmolb.2025.1668400. This article has 0 citations and is from a poor quality or predatory journal.

  8. (mroueh2024preclinicalandtranslationala pages 84-88): A Mroueh. Pre-clinical and translational studies of the expression and role of sodium glucose co-transporters sglt1 and sglt2 in arteries and hearts under physiological and …. Unknown journal, 2024.

Citations

  1. kaijage2025molecularmechanismsand pages 2-3
  2. rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70
  3. kharve2024impactofdrugmediated pages 4-7
  4. mroueh2024preclinicalandtranslationalb pages 84-88
  5. mroueh2024preclinicalandtranslational pages 84-88
  6. mroueh2024preclinicalandtranslationala pages 84-88
  7. https://doi.org/10.1002/adtp.202300143;
  8. https://doi.org/10.3389/fmolb.2025.1668400
  9. https://doi.org/10.3389/fcell.2022.1041930
  10. https://doi.org/10.1002/adtp.202300143
  11. https://doi.org/10.3390/pharmaceutics16040447
  12. https://doi.org/10.3389/fphar.2023.1142003
  13. https://doi.org/10.1002/adtp.202300143,
  14. https://doi.org/10.3389/fcell.2022.1041930,
  15. https://doi.org/10.3390/pharmaceutics16040447,
  16. https://doi.org/10.3389/fmolb.2025.1668400,

📚 Additional Documentation

Bioreason Rl Predictions

(Slc5a1-bioreason-rl-predictions.md)

BioReason Chat Export

Exported on March 22, 2026 at 01:01 AM


Organism: Rattus norvegicus

Sequence:

MDSSTLSPAVTATDAPIQSYERIRNAADISVIVIYFVVVMAVGLWAMFSTNRGTVGGFFLAGRSMVWWPIGASLFASNIGSGHFVGLAGTGAAAGIAMGGFEWNALVFVVVLGWLFVPIYIKAGVVTMPEYLRKRFGGKRIQIYLSVLSLLLYIFTKISADIFSGAIFINLALGLDIYLAIFILLAITALYTITGGLAAVIYTDTLQTAIMLVGSFILTGFAFREVGGYEAFMDKYMKAIPTLVSDGNITVKEECYTPRADSFHIFRDPITGDMPWPGLIFGLSILALWYWCTDQVIVQRCLSAKNMSHVKAGCTLCGYLKLLPMFLMVMPGMISRILYTDKIACVLPSECKKYCGTPVGCTNIAYPTLVVELMPNGLRGLMLSVMMASLMSSLTSIFNSASTLFTMDIYTKIRKGASEKELMIAGRLFILVLIGISIAWVPIVQSAQSGQLFDYIQSITSYLGPPIAAVFLLAIFCKRVNEPGAFWGLILGFLIGISRMITEFAYGTGSCMEPSNCPKIICGVHYLYFAIILFAISVVTVLVISLLTKPIPDVHLYRLCWSLRNSTEERIDLDAGEEEPVEEDPKDTIEIDAEAPQKEKGCFRKAYDLFCGLDQDKGPKMTKEEEEAMKLKMTDTSEKPLWRTVVNINGIILLAVAVFCHAYFA

Thinking Trace

I begin with the InterPro architecture. The core of the protein is defined by IPR001734 (Sodium/solute symporter family) spanning residues 25–506, which establishes a canonical sodium-coupled symporter scaffold. This scaffold is reinforced and generalized by IPR038377 (Sodium/glucose symporter superfamily) extending from residues 46–570, indicating an overall fold that coordinates Na+ with neutral or charged solutes through a multi-pass membrane topology. Embedded within this core, IPR018212 (Sodium/solute symporter, conserved site) from residues 174–494 marks a conserved functional region that typically harbors the Na+-coordination motifs and gating elements that drive alternating-access transport. The ordered layout—family-defining core (25–506), superfamily envelope (46–570), and a conserved catalytic site (174–494)—causally specifies a Na+-coupled transporter mechanism rather than a channel or ATP-driven pump.

This architecture dictates the molecular function: a secondary-active transporter that uses the inwardly directed Na+ electrochemical gradient to cotransport small solutes—here, neutral organic anions such as steroid sulfates and other circulating metabolites—across the membrane. That mechanism corresponds to GO:0015075 (molecular function) as the formal label for transport activity in this framework. The conserved-site signature and family membership causally support a tightly coupled, energy-harvesting transport cycle rather than facilitated diffusion.

From this function, I infer the biological process. Sodium-driven uptake of steroid sulfates and other endogenous anions integrates into epithelial and entoraceous solute handling, contributing to systemic solute balance and hormone precursor routing. This situates the protein squarely in transport-centered physiology, consistent with GO:0051234 (biological process). By harnessing Na+ gradients, the transporter supports epithelial absorption and transcellular flux pathways that maintain solute homeostasis.

Cellular location follows directly from the fold and mechanism. The sodium/solute symporter superfamily comprises multi-pass membrane proteins that embed stably in lipid bilayers; the long internal architecture and conserved transmembrane region predict a polytopic topology. This supports a membrane-resident role and matches a multi-pass membrane protein assignment. In epithelial contexts, such transporters typically populate apical or basolateral membranes to interface with luminal or interstitial solute pools; thus I infer localization as an integral membrane component.

Mechanistically, the transporter likely operates via an alternating-access cycle: Na+ binding to conserved sites stabilizes an outward-open state that captures steroid sulfates or other anions; cooperative binding triggers a conformational switch to inward-open, releasing both Na+ and substrate into the cytosol. This cycle predicts interaction partners that sustain its function. I hypothesize transient complexes with Na+-handling and trafficking machinery that maintain and regulate Na+-coupled uptake: apical Na+/K+-ATPase activity sets the driving force; PDZ-domain scaffolds and endocytic adaptors likely position and recycle the transporter; cytoskeletal linkers may stabilize membrane microdomains. Together, these interactions would tune surface abundance and transport capacity to match solute availability and physiological demand.

Functional Summary

A multi-pass membrane transporter in rat that harnesses the inward sodium gradient to cotransport steroid sulfates and other circulating metabolites across cellular membranes. Its transmembrane architecture supports an alternating-access mechanism that couples Na+ binding to solute uptake, thereby contributing to epithelial and entoraceous solute handling and systemic homeostasis. The protein resides as an integral membrane component and likely operates at specialized membrane domains where sodium-driven transport is energetically favored.

UniProt Summary

Acts as a sodium-dependent anion transporter, able to transport steroid sulfates and several other endogenous compounds such as myo-inositol, 3,4-methylenedioxymethamphetamine (摇头娃娃) and D-methamphetamine.

InterPro Domains

  • Sodium/solute symporter (IPR001734, family) — residues 25-506
  • Sodium/glucose symporter superfamily (IPR038377, homologous_superfamily) — residues 46-570
  • Sodium/solute symporter, conserved site (IPR018212, conserved_site) — residues 174-494

GO Terms

Molecular Function: molecular_function (GO:0003674), transporter activity (GO:0005215), transmembrane transporter activity (GO:0022857), salt transmembrane transporter activity (GO:1901702), GO:0005215 (GO:0015075), inorganic molecular entity transmembrane transporter activity (GO:0015318), carbohydrate transmembrane transporter activity (GO:0015144), active transmembrane transporter activity (GO:0022804), inorganic cation transmembrane transporter activity (GO:0022890), carbohydrate:monoatomic cation symporter activity (GO:0005402), active monoatomic ion transmembrane transporter activity (GO:0022853), sugar transmembrane transporter activity (GO:0051119), monoatomic cation transmembrane transporter activity (GO:0008324), sodium ion transmembrane transporter activity (GO:0015081), secondary active transmembrane transporter activity (GO:0015291), symporter activity (GO:0015293), monosaccharide transmembrane transporter activity (GO:0015145), solute:monoatomic cation symporter activity (GO:0015294), metal ion transmembrane transporter activity (GO:0046873), solute:sodium symporter activity (GO:0015370), hexose transmembrane transporter activity (GO:0015149), glucose transmembrane transporter activity (GO:0005355)

Biological Process: biological_process (GO:0008150), cellular process (GO:0009987), localization (GO:0051179), multicellular organismal process (GO:0032501), GO:0009987 (GO:0051234), digestion (GO:0007586), transmembrane transport (GO:0055085), system process (GO:0003008), digestive system process (GO:0022600), carbohydrate transmembrane transport (GO:0034219), transport (GO:0006810), intestinal absorption (GO:0050892), monosaccharide transmembrane transport (GO:0015749), organic substance transport (GO:0071702), hexose transmembrane transport (GO:0008645), carbohydrate transport (GO:0008643), glucose transmembrane transport (GO:1904659)

Cellular Component: cellular_component (GO:0005575), cellular anatomical entity (GO:0110165), intracellular anatomical structure (GO:0005622), organelle (GO:0043226), GO:0043226 (GO:0045178), apical part of cell (GO:0045177), cell projection (GO:0042995), membrane (GO:0016020), cell junction (GO:0030054), cell periphery (GO:0071944), cluster of actin-based cell projections (GO:0098862), basal plasma membrane (GO:0009925), plasma membrane region (GO:0098590), plasma membrane bounded cell projection (GO:0120025), intracellular organelle (GO:0043229), brush border (GO:0005903), anchoring junction (GO:0070161), plasma membrane (GO:0005886), apical plasma membrane (GO:0016324), brush border membrane (GO:0031526), cell projection membrane (GO:0031253), basolateral plasma membrane (GO:0016323), cell-cell junction (GO:0005911)


Generated by BioReason

Bioreason Rl Review

(Slc5a1-bioreason-rl-review.md)

BioReason-Pro RL Review: Slc5a1 (rat)

Source: Slc5a1-bioreason-rl-predictions.md

  • Correctness: 2/5
  • Completeness: 2/5

Functional Summary Review

The functional summary states:

A multi-pass membrane transporter in rat that harnesses the inward sodium gradient to cotransport steroid sulfates and other circulating metabolites across cellular membranes. Its transmembrane architecture supports an alternating-access mechanism that couples Na+ binding to solute uptake, thereby contributing to epithelial and entoraceous solute handling and systemic homeostasis.

This contains a fundamental error. Slc5a1 (SGLT1) is the sodium/glucose cotransporter 1, a high-affinity Na+-coupled symporter that actively transports D-glucose and D-galactose with 2:1 Na+:glucose stoichiometry. The curated review clearly identifies glucose transmembrane transporter activity (GO:0005355), glucose transmembrane transport (GO:1904659), monosaccharide transmembrane transport (GO:0015749), intestinal absorption (GO:0050892), and apical plasma membrane localization (GO:0016324).

BioReason incorrectly identifies the substrate as "steroid sulfates and other circulating metabolites." This error appears to stem from the UniProt summary for this entry, which mentions sodium-dependent anion transport of steroid sulfates. However, the UniProt entry for the rat P53790 protein -- which is indeed SGLT1 (Slc5a1) -- apparently describes a broader sodium/solute symporter capacity that is misleading. The core, best-characterized function of SGLT1 is glucose/galactose transport, not steroid sulfate transport. The BioReason system appears to have been misled by the UniProt summary text rather than correctly prioritizing the glucose transport function that is overwhelmingly supported by the curated annotations.

Furthermore, the term "entoraceous" is not a standard biological term. The correct context is intestinal epithelial cells (enterocytes) in the brush border membrane for dietary sugar absorption, and proximal tubule cells in the kidney for glucose reabsorption.

The curated review has extensive annotations including solute:sodium symporter activity (GO:0015370), carbohydrate:cation symporter activity (GO:0005402), apical plasma membrane (GO:0016324), brush border membrane (GO:0031526), and specific localization in intestine and kidney -- none of which are accurately captured.

Comparison with interpro2go:

The interpro2go annotations for Slc5a1 include membrane (GO:0016020), transmembrane transporter activity (GO:0022857), and transmembrane transport (GO:0055085). BioReason recapitulates the membrane localization and transporter activity at this general level. However, BioReason's predicted GO terms (shown at the bottom of the file) actually include glucose transmembrane transporter activity (GO:0005355) and glucose transmembrane transport (GO:1904659), suggesting the model's GO term predictions are more accurate than its functional summary narrative. The functional summary diverges from the model's own GO predictions by emphasizing steroid sulfates over glucose.

Notes on thinking trace

The trace correctly identifies the sodium/solute symporter family (IPR001734) and sodium/glucose symporter superfamily (IPR038377) but then inexplicably focuses on steroid sulfates rather than glucose as the primary substrate. This is a clear case where the domain names ("sodium/glucose symporter") should have guided the narrative toward glucose transport. The alternating-access mechanism description is generically correct but applied to the wrong substrate. The mention of "epithelial and entoraceous solute handling" gestures toward the correct tissue context but with wrong substrate specificity.

📄 View Raw YAML

id: P53790
gene_symbol: Slc5a1
aliases:
  - Sglt1
  - SGLT1
  - Na+/glucose cotransporter 1
  - Sodium/glucose cotransporter 1
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:10116
  label: Rattus norvegicus
description: >-
  Sodium/glucose cotransporter 1 (SGLT1) is a high-affinity Na+-coupled symporter
  that actively transports D-glucose and D-galactose across the plasma membrane with
  2:1 Na+:glucose stoichiometry. SGLT1 is the primary transporter for dietary hexose
  absorption across the apical brush-border membrane of enterocytes in the small intestine.
  In kidney, it functions in the S3 segment of proximal tubules for glucose reabsorption,
  handling approximately 3% of filtered glucose. Additionally serves as a water channel
  enabling passive water transport. Located at the blood-brain barrier in endothelial
  cells.

existing_annotations:
# ============================================================================
# CELLULAR COMPONENT ANNOTATIONS
# ============================================================================

# --- Apical plasma membrane (4 annotations with different evidence) ---
  - term:
      id: GO:0016324
      label: apical plasma membrane
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation based on phylogenetic inference. SGLT1 apical localization
        is well-established
        across mammals. Direct experimental evidence in rat shows SGLT1 at apical
        membrane in
        MDCK cells (PMID:11831390), blood-brain barrier endothelial cells (PMID:14986005),
        and kidney proximal tubule S3 segments (PMID:16204409).
      action: ACCEPT
      reason: >-
        Core localization for SGLT1 function. Phylogenetic inference is well-supported
        by multiple
        direct experimental studies in rat demonstrating apical membrane localization
        in intestinal
        epithelium, renal proximal tubules, and brain endothelial cells. The N-terminal
        domain
        determines apical targeting (PMID:11831390).
      supported_by:
        - reference_id: PMID:11831390
          supporting_text: "The products of N-terminal deletion clones up to the 19th
            amino acid were localized at the apical plasma membrane"
        - reference_id: PMID:14986005
          supporting_text: "Immunostaining suggested that SGLT1 is located in the
            luminal membrane of the endothelial cells"

        - reference_id: file:rat/Slc5a1/Slc5a1-deep-research-falcon.md
          supporting_text: 'model: Edison Scientific Literature'
  - term:
      id: GO:0016324
      label: apical plasma membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: >-
        IEA annotation based on UniProtKB/Swiss-Prot subcellular location mapping.
        Redundant with IBA and IDA annotations for same term.
      action: ACCEPT
      reason: >-
        While redundant with IBA annotation, this IEA represents valid automated inference
        from UniProt subcellular location annotation. Duplicates are acceptable in
        GO as they
        represent independent evidence paths. Core localization is correct.

  - term:
      id: GO:0016324
      label: apical plasma membrane
    evidence_type: IDA
    original_reference_id: PMID:14986005
    review:
      summary: >-
        Direct experimental evidence from immunohistochemistry in rat brain capillaries
        showing
        SGLT1 in luminal (apical) membrane of blood-brain barrier endothelial cells.
      action: ACCEPT
      reason: >-
        High-quality experimental evidence demonstrating apical localization in brain
        endothelial
        cells. The study showed immunoreactivity in intracerebral capillaries with
        staining
        in the luminal membrane.
      supported_by:
        - reference_id: PMID:14986005
          supporting_text: "Immunostaining suggested that SGLT1 is located in the
            luminal membrane of the endothelial cells and in intracellular vesicles"

  - term:
      id: GO:0016324
      label: apical plasma membrane
    evidence_type: IDA
    original_reference_id: PMID:11831390
    review:
      summary: >-
        Direct experimental evidence from MDCK cell localization studies showing rat
        SGLT1
        localizes to apical plasma membrane. N-terminal deletion analysis identified
        apical
        targeting signals.
      action: ACCEPT
      reason: >-
        High-quality experimental evidence. Study used rat SGLT1 expressed in MDCK
        cells and
        demonstrated apical localization, with identification of the N-terminal targeting
        domain.
      supported_by:
        - reference_id: PMID:11831390
          supporting_text: "SGLT1, an isoform of Na+-dependent glucose cotransporters,
            is localized at the apical plasma membrane in the epithelial cells of
            the small intestine and the kidney"

  - term:
      id: GO:0016324
      label: apical plasma membrane
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation transferred from other mammalian species by RGD. Redundant
        with
        multiple direct experimental annotations (IDA) for rat SGLT1.
      action: ACCEPT
      reason: >-
        Valid ortholog transfer that is consistent with direct rat experimental evidence.
        Duplicates are acceptable as independent evidence paths.

# --- Plasma membrane (2 annotations) ---
  - term:
      id: GO:0005886
      label: plasma membrane
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation for plasma membrane localization. This is a parent term of
        apical plasma membrane (GO:0016324) which is the more specific correct localization.
      action: KEEP_AS_NON_CORE
      reason: >-
        While technically correct, this is less specific than apical plasma membrane.
        The more specific term GO:0016324 better captures SGLT1's polarized localization.
        Acceptable to retain as it captures the broader membrane context.

  - term:
      id: GO:0005886
      label: plasma membrane
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation transferred from mammalian orthologs. Less specific than apical
        plasma membrane annotations.
      action: KEEP_AS_NON_CORE
      reason: >-
        Valid but less specific than apical plasma membrane. The more specific term
        GO:0016324 is preferred for capturing SGLT1's polarized epithelial localization.

# --- Brush border membrane (2 IDA annotations) ---
  - term:
      id: GO:0031526
      label: brush border membrane
    evidence_type: IDA
    original_reference_id: PMID:14986005
    review:
      summary: >-
        Brush border membrane localization is well supported for intestinal SGLT1,
        but PMID:14986005 itself focuses on brain capillary localization. Accept the
        term based on direct intestinal apical membrane evidence from other sources.
      action: ACCEPT
      reason: >-
        The brush border membrane term is appropriate for intestinal SGLT1, even
        though PMID:14986005 is likely a misassigned reference. Experimental data
        from intestinal apical membrane preparations support this localization.
      supported_by:
        - reference_id: PMID:17272350
          supporting_text: Western blotting showed that in each case there was a
            significant decrease in apical GLUT2 level, but no change in SGLT1 level.

  - term:
      id: GO:0031526
      label: brush border membrane
    evidence_type: IDA
    original_reference_id: PMID:17272350
    review:
      summary: >-
        Direct experimental evidence showing SGLT1 at intestinal brush border membrane
        in
        rat jejunum. Western blotting confirmed SGLT1 presence in apical membrane
        preparations.
      action: ACCEPT
      reason: >-
        High-quality experimental evidence demonstrating SGLT1 at brush border membrane
        of rat intestinal epithelium. This is a core localization for intestinal glucose
        absorption.
      supported_by:
        - reference_id: PMID:17272350
          supporting_text: "Western blotting showed that in each case there was a
            significant decrease in apical GLUT2 level, but no change in SGLT1 level"

# --- Brush border (ISO) ---
  - term:
      id: GO:0005903
      label: brush border
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation for brush border localization. Brush border (GO:0005903) is
        the
        parent of brush border membrane (GO:0031526). The more specific membrane term
        is more accurate for a transmembrane transporter.
      action: MODIFY
      reason: >-
        For a transmembrane transporter, the more specific term brush border membrane
        (GO:0031526) is more appropriate than the general brush border term.
      proposed_replacement_terms:
        - id: GO:0031526
          label: brush border membrane

# --- Membrane (IEA) ---
  - term:
      id: GO:0016020
      label: membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    review:
      summary: >-
        Very general IEA annotation based on InterPro record mapping. SGLT1 has many
        more specific membrane annotations (apical plasma membrane, brush border membrane).
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        This is too general to be informative. SGLT1 has specific annotations to apical
        plasma membrane and brush border membrane that are much more informative.
        While technically correct, this adds no useful information.

# --- Organelle (IDA) ---
  - term:
      id: GO:0043226
      label: organelle
    evidence_type: IDA
    original_reference_id: PMID:14986005
    review:
      summary: >-
        The paper mentions intracellular vesicles containing SGLT1 in brain endothelial
        cells. However, 'organelle' is extremely vague and should be more specific.
      action: MODIFY
      reason: >-
        The paper specifically mentions intracellular vesicles, not generic organelles.
        A more specific term would be appropriate if we want to capture this localization.
      proposed_replacement_terms:
        - id: GO:0031410
          label: cytoplasmic vesicle
      supported_by:
        - reference_id: PMID:14986005
          supporting_text: "Immunostaining suggested that SGLT1 is located in the
            luminal membrane of the endothelial cells and in intracellular vesicles"

# --- Basolateral plasma membrane (TAS) ---
  - term:
      id: GO:0016323
      label: basolateral plasma membrane
    evidence_type: TAS
    original_reference_id: PMID:14986005
    review:
      summary: >-
        Questionable annotation. PMID:14986005 specifically shows SGLT1 in the LUMINAL
        (apical) membrane of brain endothelial cells, not basolateral. This appears
        to
        be an error in annotation.
      action: REMOVE
      reason: >-
        The cited paper explicitly states SGLT1 is in the luminal membrane, which
        is the
        apical/blood-facing side of brain capillary endothelium, not basolateral.
        SGLT1
        is canonically an apical transporter; basolateral glucose exit is mediated
        by GLUT2.
      supported_by:
        - reference_id: PMID:14986005
          supporting_text: "Immunostaining suggested that SGLT1 is located in the
            luminal membrane of the endothelial cells"

# --- Cell-cell junction (IDA) ---
  - term:
      id: GO:0005911
      label: cell-cell junction
    evidence_type: IDA
    original_reference_id: PMID:17090404
    review:
      summary: >-
        Direct experimental evidence showing SGLT1 clusters at cell-cell junctions
        in
        arterial endothelium. High-density clusters found in proximity to cell-to-cell
        junctions.
      action: KEEP_AS_NON_CORE
      reason: >-
        Valid experimental finding in endothelial cells showing SGLT1 clustering near
        cell-cell junctions. This represents a secondary localization pattern in vascular
        endothelium, not the primary physiological localization in intestine/kidney.
      supported_by:
        - reference_id: PMID:17090404
          supporting_text: "Clusters of the glucose transporter isoforms were found
            at a high density in proximity to the cell-to-cell junctions"

# --- Early endosome (ISO) ---
  - term:
      id: GO:0005769
      label: early endosome
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation from mammalian orthologs. SGLT1 trafficking through endosomal
        compartments is plausible for membrane protein recycling.
      action: KEEP_AS_NON_CORE
      reason: >-
        Likely reflects trafficking/recycling rather than steady-state functional
        localization. Not a core localization but may be valid for protein turnover.

# --- Perinuclear region of cytoplasm (ISO) ---
  - term:
      id: GO:0048471
      label: perinuclear region of cytoplasm
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation from orthologs. May reflect biosynthetic pathway localization
        (ER/Golgi) rather than functional localization.
      action: KEEP_AS_NON_CORE
      reason: >-
        Likely reflects biosynthetic pathway (ER/Golgi in perinuclear region) rather
        than functional localization. Not a core localization for SGLT1 function.

# ============================================================================
# MOLECULAR FUNCTION ANNOTATIONS
# ============================================================================

# --- D-glucose:sodium symporter activity (4 annotations) ---
  - term:
      id: GO:0005412
      label: D-glucose:sodium symporter activity
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        Core molecular function of SGLT1 - IBA based on phylogenetic inference.
        This is the defining activity of the SGLT1 transporter family.
      action: ACCEPT
      reason: >-
        This is THE core molecular function of SGLT1. The transporter catalyzes
        2 Na+ : 1 D-glucose cotransport as established across all species.
        UniProt confirms this catalytic activity with Rhea reaction annotation.
      supported_by:
        - reference_id: PMID:15829715
          supporting_text: "the renal brush-border membrane Na+/glucose co-transporter-1
            (SGLT1) is a molecular target for Cd2+ toxicity"

  - term:
      id: GO:0005412
      label: D-glucose:sodium symporter activity
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation from mammalian orthologs. Consistent with direct rat evidence.
      action: ACCEPT
      reason: >-
        Core molecular function, well-supported by direct rat experimental evidence
        and consistent phylogenetic conservation.

  - term:
      id: GO:0005412
      label: D-glucose:sodium symporter activity
    evidence_type: IDA
    original_reference_id: PMID:15829715
    review:
      summary: >-
        Direct experimental evidence showing rat SGLT1 Na+/glucose cotransport activity.
        Study used methyl-D-glucopyranoside uptake assays in SGLT1-expressing cells.
      action: ACCEPT
      reason: >-
        High-quality direct experimental evidence demonstrating the core molecular
        function in rat SGLT1.
      supported_by:
        - reference_id: PMID:15829715
          supporting_text: "Cd2+ acted as a noncompetitive, partial inhibitor of methyl-D-glucopyranoside
            uptake in vesicles from COS-7 cells transiently expressing SGLT1"

  - term:
      id: GO:0005412
      label: D-glucose:sodium symporter activity
    evidence_type: TAS
    original_reference_id: PMID:11831390
    review:
      summary: >-
        TAS annotation from paper on SGLT1 apical localization. Paper discusses SGLT1
        as glucose transporter but main focus is localization not transport activity.
      action: ACCEPT
      reason: >-
        The paper refers to SGLT1's known function as Na+-dependent glucose cotransporter.
        While the experimental focus is localization, the stated function is accurate.
      supported_by:
        - reference_id: PMID:11831390
          supporting_text: "SGLT1, an isoform of Na+-dependent glucose cotransporters,
            is localized at the apical plasma membrane"

# --- Galactose:sodium symporter activity (2 annotations) ---
  - term:
      id: GO:0015371
      label: galactose:sodium symporter activity
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation for galactose transport. SGLT1 transports both D-glucose and
        D-galactose with similar affinity - this is well-established in the literature.
      action: ACCEPT
      reason: >-
        Core molecular function. SGLT1 transports D-galactose as well as D-glucose,
        both with high affinity. UniProt catalytic activity annotation confirms this.
        PMID:16204409 used galactose uptake to measure SGLT1 activity.
      supported_by:
        - reference_id: PMID:16204409
          supporting_text: "The phlorizin-sensitive uptake of d-[(3)H]galactose in
            BBM vesicles"

  - term:
      id: GO:0015371
      label: galactose:sodium symporter activity
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation based on sequence similarity. Consistent with ISO annotation
        and UniProt functional annotation.
      action: ACCEPT
      reason: >-
        Core molecular function. Galactose transport by SGLT1 is well-established
        and conserved across species.

# --- Water transmembrane transporter activity (2 annotations) ---
  - term:
      id: GO:0005372
      label: water transmembrane transporter activity
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation for water transport. SGLT1 functions as a water channel with
        high water conductivity comparable to aquaporins, enabling passive water transport.
      action: ACCEPT
      reason: >-
        Core molecular function. UniProt describes SGLT1 as having high water conductivity
        comparable to aquaporins, enabling passive water transport in response to
        osmotic
        gradients created during sugar/Na+ uptake.

  - term:
      id: GO:0005372
      label: water transmembrane transporter activity
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation from orthologs for water transport activity.
      action: ACCEPT
      reason: >-
        Core molecular function. Water transport by SGLT1 is well-documented and
        important for transepithelial water permeability in intestine.

# --- D-glucose transmembrane transporter activity (ISO) ---
  - term:
      id: GO:0055056
      label: D-glucose transmembrane transporter activity
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation for general glucose transporter activity. This is less specific
        than D-glucose:sodium symporter activity which captures the coupling mechanism.
      action: KEEP_AS_NON_CORE
      reason: >-
        While correct, this is less informative than D-glucose:sodium symporter activity
        (GO:0005412) which specifies the sodium-coupling mechanism that defines SGLT1.

# --- Alpha-glucoside transmembrane transporter activity (ISO) ---
  - term:
      id: GO:0015151
      label: alpha-glucoside transmembrane transporter activity
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation for alpha-glucoside transport. SGLT1 transports glucose (an
        alpha-glucoside in its cyclic form), but this term is typically used for
        disaccharide transport (e.g., maltose, sucrose). May be an over-annotation.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        SGLT1 transports monosaccharides (glucose, galactose), not alpha-glucosides
        like maltose or sucrose. The more accurate term is D-glucose:sodium symporter
        activity. This term implies transport of glycosides/disaccharides which is
        not the primary function.

# --- Symporter activity (IEA) ---
  - term:
      id: GO:0015293
      label: symporter activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: >-
        IEA annotation from UniProtKB keyword mapping. Very general term.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Too general. The specific term D-glucose:sodium symporter activity (GO:0005412)
        is much more informative and captures the actual substrate specificity.

# --- Transmembrane transporter activity (IEA) ---
  - term:
      id: GO:0022857
      label: transmembrane transporter activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    review:
      summary: >-
        Very general IEA annotation from InterPro mapping.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Far too general to be informative. Specific molecular function annotations
        (D-glucose:sodium symporter activity) provide the relevant information.

# --- Monoatomic cation transmembrane transporter activity (IEA) ---
  - term:
      id: GO:0008324
      label: monoatomic cation transmembrane transporter activity
    evidence_type: IEA
    original_reference_id: GO_REF:0000117
    review:
      summary: >-
        IEA from ARBA machine learning. SGLT1 uses Na+ gradient to drive glucose transport
        but is not primarily a cation transporter - it is a sugar transporter.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Misleading annotation. While SGLT1 translocates Na+ ions, it is primarily
        a
        sugar transporter that uses the Na+ gradient as driving force. The sodium
        transport is coupled to/incidental to the primary glucose transport function.

# ============================================================================
# BIOLOGICAL PROCESS ANNOTATIONS
# ============================================================================

# --- Intestinal D-glucose absorption (3 annotations) ---
  - term:
      id: GO:0001951
      label: intestinal D-glucose absorption
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation for intestinal glucose absorption - THE core biological process
        for SGLT1 in the gut.
      action: ACCEPT
      reason: >-
        Core biological process. SGLT1 is the primary transporter for dietary glucose
        absorption across enterocyte brush border membrane.
      supported_by:
        - reference_id: PMID:17272350
          supporting_text: "We have proposed a model of intestinal glucose absorption
            in which transport by SGLT1 induces rapid insertion and activation of
            GLUT2"

  - term:
      id: GO:0001951
      label: intestinal D-glucose absorption
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation from orthologs. Consistent with direct rat evidence.
      action: ACCEPT
      reason: >-
        Core biological process, well-supported by rat experimental evidence.

  - term:
      id: GO:0001951
      label: intestinal D-glucose absorption
    evidence_type: TAS
    original_reference_id: PMID:15829715
    review:
      summary: >-
        TAS annotation. The paper's main focus is cadmium inhibition of SGLT1, but
        mentions intestinal glucose absorption as established SGLT1 function.
      action: ACCEPT
      reason: >-
        Core biological process. While paper focuses on cadmium effects, it references
        SGLT1's role in intestinal glucose absorption.

# --- Renal D-glucose absorption (3 annotations) ---
      supported_by:
        - reference_id: PMID:15829715
          supporting_text: 2005 Apr 13. The endogenous CXXC motif governs the 
            cadmium sensitivity of the renal Na+/glucose co-transporter.
  - term:
      id: GO:0035623
      label: renal D-glucose absorption
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation for renal glucose reabsorption. SGLT1 handles glucose reabsorption
        in S3 segment of proximal tubule (minor fraction, ~3% of total).
      action: ACCEPT
      reason: >-
        Core biological process. PMID:16204409 directly demonstrates SGLT1 in rat
        kidney
        S3 proximal tubule segments with functional glucose transport activity.
      supported_by:
        - reference_id: PMID:16204409
          supporting_text: "SGLT1 (SLC5A1) mediates a part of glucose and galactose
            reabsorption in the mammalian proximal tubule"
        - reference_id: PMID:16204409
          supporting_text: "the expression of SGLT1 is represented by a 75-kDa protein
            localized largely in the PT S3 segments"

  - term:
      id: GO:0035623
      label: renal D-glucose absorption
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation from sequence similarity. Consistent with direct rat evidence.
      action: ACCEPT
      reason: >-
        Core biological process, well-supported by direct rat experimental evidence.

  - term:
      id: GO:0035623
      label: renal D-glucose absorption
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation from orthologs. Consistent with IBA and direct rat evidence.
      action: ACCEPT
      reason: >-
        Core biological process with strong experimental support in rat.

# --- D-glucose import across plasma membrane (2 annotations) ---
  - term:
      id: GO:0098708
      label: D-glucose import across plasma membrane
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation for glucose import. Accurate description of SGLT1's transport
        direction (import into cell).
      action: ACCEPT
      reason: >-
        Core biological process. SGLT1 imports glucose from lumen into epithelial
        cells.
        This is a fundamental aspect of its transport function.

  - term:
      id: GO:0098708
      label: D-glucose import across plasma membrane
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation from orthologs. Consistent with IBA annotation.
      action: ACCEPT
      reason: >-
        Core biological process describing the import direction of SGLT1-mediated
        glucose transport.

# --- D-glucose transmembrane transport (2 annotations) ---
  - term:
      id: GO:1904659
      label: D-glucose transmembrane transport
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation for glucose transmembrane transport.
      action: ACCEPT
      reason: >-
        Core biological process. This is the primary transport function of SGLT1.

  - term:
      id: GO:1904659
      label: D-glucose transmembrane transport
    evidence_type: TAS
    original_reference_id: PMID:11831390
    review:
      summary: >-
        TAS annotation. Paper focuses on localization but references SGLT1's glucose
        transport function.
      action: ACCEPT
      reason: >-
        Core biological process. While paper's experimental focus is localization,
        SGLT1's glucose transport function is accurately referenced.
      supported_by:
        - reference_id: PMID:11831390
          supporting_text: "SGLT1 glucose transporter...plays a pivotal role in the
            absorption and reabsorption of sugars"

# --- Galactose transmembrane transport (IEA) ---
  - term:
      id: GO:0015757
      label: galactose transmembrane transport
    evidence_type: IEA
    original_reference_id: GO_REF:0000108
    review:
      summary: >-
        IEA annotation based on logical inference. SGLT1 transports galactose with
        similar affinity to glucose - this is experimentally demonstrated in rat.
      action: ACCEPT
      reason: >-
        Core biological process. Galactose transport by SGLT1 is well-established.
        PMID:16204409 used galactose uptake assays to measure rat SGLT1 activity.
      supported_by:
        - reference_id: PMID:16204409
          supporting_text: "SGLT1 (SLC5A1) mediates a part of glucose and galactose
            reabsorption in the mammalian proximal tubule"

# --- Intestinal absorption (2 annotations) ---
  - term:
      id: GO:0050892
      label: intestinal absorption
    evidence_type: TAS
    original_reference_id: PMID:16204409
    review:
      summary: >-
        TAS annotation. The paper primarily focuses on kidney, though it mentions
        intestinal absorption as SGLT1 function.
      action: ACCEPT
      reason: >-
        Core biological process. SGLT1's role in intestinal absorption is well-established.
      supported_by:
        - reference_id: PMID:16204409
          supporting_text: "SGLT1 (SLC5A1) mediates a part of glucose and galactose
            reabsorption in the mammalian proximal tubule"

  - term:
      id: GO:0050892
      label: intestinal absorption
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation from orthologs. Consistent with known SGLT1 function.
      action: ACCEPT
      reason: >-
        Core biological process for SGLT1 in the gut.

# --- Transepithelial water transport (ISO) ---
  - term:
      id: GO:0035377
      label: transepithelial water transport
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation for water transport function. SGLT1 acts as a water channel
        with high conductivity comparable to aquaporins.
      action: ACCEPT
      reason: >-
        Core biological process. SGLT1's water transport activity is important for
        intestinal water absorption coupled to glucose/Na+ uptake.

# --- Sodium ion import across plasma membrane (ISO) ---
  - term:
      id: GO:0098719
      label: sodium ion import across plasma membrane
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation for sodium import. SGLT1 couples 2 Na+ import per glucose.
      action: KEEP_AS_NON_CORE
      reason: >-
        While technically accurate (SGLT1 imports 2 Na+ per glucose), sodium transport
        is secondary to the primary function of glucose transport. The Na+ gradient
        drives glucose uptake rather than being the primary transported substrate.

# --- Sodium ion transport (IEA) ---
  - term:
      id: GO:0006814
      label: sodium ion transport
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: >-
        IEA annotation from UniProtKB keyword mapping.
      action: KEEP_AS_NON_CORE
      reason: >-
        While Na+ is cotransported with glucose, this annotation may give the misleading
        impression that SGLT1 is primarily a sodium transporter. The primary function
        is glucose transport using the Na+ gradient.

# --- Monoatomic ion transport (IEA) ---
  - term:
      id: GO:0006811
      label: monoatomic ion transport
    evidence_type: IEA
    original_reference_id: GO_REF:0000043
    review:
      summary: >-
        Very general IEA annotation for ion transport.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Too general and misleading. SGLT1 is a sugar transporter that cotransports
        sodium, not primarily an ion transporter.

# --- Transmembrane transport (IEA) ---
  - term:
      id: GO:0055085
      label: transmembrane transport
    evidence_type: IEA
    original_reference_id: GO_REF:0000002
    review:
      summary: >-
        Very general IEA annotation from InterPro mapping.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Far too general to be informative. Specific process annotations provide the
        relevant information about SGLT1 function.

# --- Transport across blood-brain barrier (ISO) ---
  - term:
      id: GO:0150104
      label: transport across blood-brain barrier
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation for BBB transport. Rat experimental evidence shows SGLT1
        in brain capillary endothelium with upregulation after ischemia.
      action: KEEP_AS_NON_CORE
      reason: >-
        Valid annotation supported by rat experimental evidence (PMID:14986005).
        Not a core function (intestine/kidney are primary sites) but represents
        an established secondary physiological role.
      supported_by:
        - reference_id: PMID:14986005
          supporting_text: "The data suggest that SGLT1 participates in transport
            of D-glucose across the blood-brain barrier"

# --- Chloride transmembrane transport (ISO) ---
  - term:
      id: GO:1902476
      label: chloride transmembrane transport
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    negated: true
    review:
      summary: >-
        ISO annotation for chloride transport. This is unexpected - SGLT1 is not
        known as a chloride transporter. May be an erroneous annotation.
      action: UNDECIDED
      reason: >-
        SGLT1 is a Na+/glucose symporter, not a chloride transporter. The basis for
        this annotation is unclear. Would need to trace the original evidence from
        the ortholog to evaluate. Marking as undecided pending clarification.

# --- Alpha-glucoside transport (ISO) ---
  - term:
      id: GO:0000017
      label: alpha-glucoside transport
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation for alpha-glucoside transport. SGLT1 transports monosaccharides,
        not glucosides (which typically refers to disaccharides).
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        SGLT1 transports D-glucose and D-galactose (monosaccharides), not alpha-glucosides
        like maltose or sucrose. This term is misleading for SGLT1's actual substrate
        specificity.

# --- Carbohydrate utilization (IDA) ---
  - term:
      id: GO:0009758
      label: carbohydrate utilization
    evidence_type: IDA
    original_reference_id: PMID:25592016
    review:
      summary: >-
        IDA annotation from study on dietary regulation of Sglt1 gene expression.
        The paper shows epigenetic regulation (H3K4 methylation) of Sglt1 in response
        to high-starch diet, not direct SGLT1 involvement in carbohydrate utilization.
      action: MODIFY
      reason: >-
        The paper demonstrates transcriptional regulation of Sglt1 by diet, not a
        direct
        role for SGLT1 protein in carbohydrate utilization. The appropriate process
        would be related to glucose absorption/transport, not utilization.
      proposed_replacement_terms:
        - id: GO:0001951
          label: intestinal D-glucose absorption
      supported_by:
        - reference_id: PMID:25592016
          supporting_text: "Feeding rats the high-starch/low-fat diet induced mono-,
            di-, and trimethylation of histone H3K4 on the promoter and transcribed
            regions of the Si and Sglt1 genes"

# --- Metanephros development (ISO) ---
  - term:
      id: GO:0001656
      label: metanephros development
    evidence_type: ISO
    original_reference_id: GO_REF:0000121
    review:
      summary: >-
        ISO annotation for kidney development. SGLT1 is a glucose transporter that
        is expressed during kidney development but is not known to have a developmental
        signaling role.
      action: UNDECIDED
      reason: >-
        The basis for this developmental annotation is unclear. SGLT1 may be expressed
        during kidney development but is primarily a glucose transporter, not a
        developmental regulator. Would need to evaluate the original ortholog evidence.

references:
  - id: GO_REF:0000002
    title: Gene Ontology annotation through association of InterPro records with
      GO terms
    findings: []
  - id: GO_REF:0000024
    title: Manual transfer of experimentally-verified manual GO annotation data 
      to orthologs by curator judgment of sequence similarity
    findings: []
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings: []
  - id: GO_REF:0000043
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword 
      mapping
    findings: []
  - id: GO_REF:0000044
    title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular 
      Location vocabulary mapping
    findings: []
  - id: GO_REF:0000108
    title: Automatic assignment of GO terms using logical inference, based on 
      inter-ontology links
    findings: []
  - id: GO_REF:0000117
    title: Electronic Gene Ontology annotations created by ARBA machine learning
      models
    findings: []
  - id: GO_REF:0000121
    title: RGD ISO annotations to rat from other mammalian species
    findings: []
  - id: PMID:11831390
    title: The apical localization of SGLT1 glucose transporter is determined by
      the short amino acid sequence in its N-terminal domain.
    findings:
      - statement: N-terminal domain (first 19 amino acids) determines apical 
          localization in MDCK cells
        supporting_text: "The products of N-terminal deletion clones up to the 19th
          amino acid were localized at the apical plasma membrane, whereas the products
          of N-terminal 20- and 23-amino-acid deletion clones were localized along
          the entire plasma membrane."
      - statement: D28 mutations cause cytoplasmic retention
        supporting_text: "The products of D28N and D28G clones were localized in the
          cytoplasm, showing that the aspartic acid-28 may be essential for the delivery
          of SGLT1 to the plasma membrane."
  - id: PMID:14986005
    title: Localization of the Na+-D-glucose cotransporter SGLT1 in the 
      blood-brain barrier.
    findings:
      - statement: SGLT1 located in luminal membrane of brain capillary 
          endothelial cells
        supporting_text: "Immunostaining suggested that SGLT1 is located in the luminal
          membrane of the endothelial cells and in intracellular vesicles."
      - statement: Also found in intracellular vesicles
        supporting_text: "Immunostaining suggested that SGLT1 is located in the luminal
          membrane of the endothelial cells and in intracellular vesicles."
      - statement: SGLT1 mRNA upregulated after brain ischemia
        supporting_text: "1 day after a transient occlusion of the right middle cerebral
          artery, SGLT1 mRNA was detected in capillaries of both brain hemispheres."
  - id: PMID:15829715
    title: The endogenous CXXC motif governs the cadmium sensitivity of the 
      renal Na+/glucose co-transporter.
    findings:
      - statement: SGLT1 is a target for Cd2+ toxicity via CXXC motif
        supporting_text: "the renal brush-border membrane Na+/glucose co-transporter-1
          (SGLT1) is a molecular target for Cd2+ toxicity"
      - statement: Demonstrated Na+/glucose cotransport activity
        supporting_text: "Cd2+ acted as a noncompetitive, partial inhibitor of methyl-D-glucopyranoside
          uptake in vesicles from COS-7 cells transiently expressing SGLT1"
  - id: PMID:16204409
    title: Rat renal glucose transporter SGLT1 exhibits zonal distribution and 
      androgen-dependent gender differences.
    findings:
      - statement: SGLT1 localized to S3 segment of proximal tubule
        supporting_text: "the expression of SGLT1 is represented by a 75-kDa protein
          localized largely in the PT S3 segments"
      - statement: Gender differences in expression (female > male)
        supporting_text: "In tissue cryosections, the antibody strongly stained BBM
          of the S3 PT segments in the OS and medullary rays (F > M)"
      - statement: Androgen-dependent regulation
        supporting_text: "castration upregulated, whereas treatment of castrated rats
          with testosterone, but not with estradiol or progesterone, downregulated
          the 75-kDa protein"
  - id: PMID:17090404
    title: Asymmetric subcellular distribution of glucose transporters in the 
      endothelium of small contractile arteries.
    findings:
      - statement: SGLT1 present in vascular endothelium
        supporting_text: "We identified GLUT-1 to -5 and SGLT-1 in the endothelial
          cells of all three vascular beds."
      - statement: Clusters at cell-cell junctions
        supporting_text: "Clusters of the glucose transporter isoforms were found
          at a high density in proximity to the cell-to-cell junctions."
  - id: PMID:17272350
    title: 'Apical GLUT2 and Cav1.3: regulation of rat intestinal glucose and calcium
      absorption.'
    findings:
      - statement: SGLT1 at brush border membrane of jejunum
        supporting_text: "Western blotting showed that in each case there was a significant
          decrease in apical GLUT2 level, but no change in SGLT1 level."
      - statement: SGLT1 transport initiates GLUT2 insertion
        supporting_text: "We have proposed a model of intestinal glucose absorption
          in which transport by SGLT1 induces rapid insertion and activation of GLUT2
          in the apical membrane"
      - statement: SGLT1 component is phloretin-insensitive
        supporting_text: "the phloretin-insensitive SGLT1 component of glucose absorption"
  - id: PMID:25592016
    title: Induction of histone H3K4 methylation at the promoter, enhancer, and 
      transcribed regions of the Si and Sglt1 genes in rat jejunum in response 
      to a high-starch/low-fat diet.
    findings:
      - statement: Sglt1 gene expression induced by high-starch diet
        supporting_text: "induction of Si and Sglt1 gene expression in rat jejunum
          by a high-starch/low-fat diet intake is positively associated with histone
          H3K4 methylation"
      - statement: Epigenetic regulation via H3K4 methylation
        supporting_text: "Feeding rats the high-starch/low-fat diet induced mono-,
          di-, and trimethylation of histone H3K4 on the promoter and transcribed
          regions of the Si and Sglt1 genes"

  - id: file:rat/Slc5a1/Slc5a1-deep-research-falcon.md
    title: Deep research report on Slc5a1
    findings: []
core_functions:
  - description: >-
      Primary molecular function - electrogenic Na+-coupled D-glucose symporter with
      2:1 Na+:glucose stoichiometry
    molecular_function:
      id: GO:0005412
      label: D-glucose:sodium symporter activity
    directly_involved_in:
      - id: GO:0001951
        label: intestinal D-glucose absorption
      - id: GO:0035623
        label: renal D-glucose absorption
    locations:
      - id: GO:0016324
        label: apical plasma membrane
      - id: GO:0031526
        label: brush border membrane
  - description: >-
      Co-transports D-galactose with sodium using same mechanism as glucose transport
    molecular_function:
      id: GO:0015371
      label: galactose:sodium symporter activity
    directly_involved_in:
      - id: GO:0015757
        label: galactose transmembrane transport
    locations:
      - id: GO:0016324
        label: apical plasma membrane
  - description: >-
      Acts as water channel with high conductivity comparable to aquaporins
    molecular_function:
      id: GO:0005372
      label: water transmembrane transporter activity
    directly_involved_in:
      - id: GO:0035377
        label: transepithelial water transport
    locations:
      - id: GO:0016324
        label: apical plasma membrane